Company / PP&E per Share
Aligos Therapeutics, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.02
FY2025
5-year range
$0.02 / $0.79
FY2021-FY2025
Trend
-97.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.08 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -59.1%.
Declined from $0.08 to $0.02 over the past 2 years.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- -59.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e per share decreased 97.0% year-over-year.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -97.0% |
| FY2024 | $0.79 | +935.6% |
| FY2023 | $0.08 | -32.7% |
| FY2022 | $0.11 | -30.4% |
| FY2021 | $0.16 | -92.0% |
| FY2020 | $2.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026